3-{4-[(1-Isopropyl-1H-indazole-3-carbonyl)-amino]-piperidin-1-yl}-2,2-dimethylpropionicacid tartarate

ID: ALA5283568

Max Phase: Preclinical

Molecular Formula: C25H36N4O9

Molecular Weight: 386.50

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)n1nc(C(=O)NC2CCN(CC(C)(C)C(=O)O)CC2)c2ccccc21.O=C(O)C(O)C(O)C(=O)O

Standard InChI:  InChI=1S/C21H30N4O3.C4H6O6/c1-14(2)25-17-8-6-5-7-16(17)18(23-25)19(26)22-15-9-11-24(12-10-15)13-21(3,4)20(27)28;5-1(3(7)8)2(6)4(9)10/h5-8,14-15H,9-13H2,1-4H3,(H,22,26)(H,27,28);1-2,5-6H,(H,7,8)(H,9,10)

Standard InChI Key:  DNAJUDQPFHZMBB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 38 39  0  0  0  0  0  0  0  0999 V2000
    2.8059    2.5450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0098    2.7575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2239    1.9618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2060    2.5822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9526    1.7969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5054    1.1837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2543    0.4016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4472    0.2272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1968   -0.5589    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6093   -0.7352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8597   -1.5215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3698   -2.1874    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8518   -2.8591    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6394   -2.6081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3581   -3.0257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0730   -2.6128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0720   -1.7851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3600   -1.3724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6443   -1.7815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5923   -3.6424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1408   -4.2589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2158   -3.8092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1650   -0.1253    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1095    0.8346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1451    1.6223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2662    3.5408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0730    3.7142    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7140    4.1541    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1409    3.5445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5533    2.8300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1409    2.1156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5533    1.4013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3782    1.4013    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1409    0.6868    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3159    2.1156    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3782    2.8300    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3159    3.5445    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5533    4.2589    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  2  1  0
  5  4  1  0
  6  5  1  0
  7  6  1  0
  8  7  1  0
  9  8  1  0
 10  9  1  0
 11 10  1  0
 12 11  2  0
 13 12  1  0
 14 13  1  0
 15 14  2  0
 16 15  1  0
 17 16  2  0
 18 17  1  0
 19 18  2  0
 19 14  1  0
 11 19  1  0
 13 20  1  0
 20 21  1  0
 20 22  1  0
 10 23  2  0
  8 24  1  0
  5 25  1  0
 25 24  1  0
  2 26  1  0
 26 27  1  0
 26 28  2  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 31 35  1  0
 30 36  1  0
 29 37  2  0
 29 38  1  0
M  END

Associated Targets(Human)

HTR4 Tclin Serotonin 4 (5-HT4) receptor (2068 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 386.50Molecular Weight (Monoisotopic): 386.2318AlogP: 2.92#Rotatable Bonds: 6
Polar Surface Area: 87.46Molecular Species: ZWITTERIONHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.37CX Basic pKa: 9.54CX LogP: -0.24CX LogD: -0.24
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.80Np Likeness Score: -1.11

References

1. Nirogi R, Mohammed AR, Shinde AK, Gagginapally SR, Kancharla DM, Ravella SR, Bogaraju N, Middekadi VR, Subramanian R, Palacharla RC, Benade V, Muddana N, Abraham R, Medapati RB, Thentu JB, Mekala VR, Petlu S, Lingavarapu BB, Yarra S, Kagita N, Goyal VK, Pandey SK, Jasti V..  (2021)  Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT4 Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer's Disease.,  64  (15.0): [PMID:34251799] [10.1021/acs.jmedchem.1c00703]

Source